Skip to content

To compare neonates having sepsis with culture positive to neonates with sepsis without culture positive in terms of their demographics, risk factors, presentations and response to antibiotics.

Comparison of clinical characteristics and outcomes of neonates with culture-negative versus culture-positive sepsis: a prospective cohort study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/02/105038
Enrollment
178
Registered
2026-02-27
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: P35-P39- Infections specific to the perinatal period

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil

Sponsors

Bharati Hospital and Research Centr
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All Neonates (0 to 28 days) admitted to NICU during the study period and clinically suspected to have sepsis by the treating neonatal physician.

Exclusion criteria

Exclusion criteria: Neonates (0 too 28 days) with the following conditions will be excluded from the study: 1. Major congenital anomalies incompatible with life 2. Blood culture not taken before starting antibiotics 3. Prior sepsis episode during the same admission and patient still not recovered 4. Only the first episode of sepsis for each patient will be included for analysis

Design outcomes

Primary

MeasureTime frame
To compare the rates of major organ dysfunction between neonates with culture-negative (probable) and culture-positive (proven) sepsis admitted to the NICU.Timepoint: Occurrence of any one or more of the Major organ dysfunction after the time of sepsis diagnosis, until the end of antimicrobial course, or 21 days, whichever is later.

Secondary

MeasureTime frame
To compare the following between neonates with culture-negative versus and culture-positive sepsis: 1. Cause-specific mortality and 28-day all-cause mortality 2. Number of major organ dysfunction secondary to sepsis 3. Morbidity rates other than major organ dysfunction 4. Antibiotic exposure patterns (duration, escalation, de-escalation, prolonged empirical use). 5. Relapse of sepsis within 72 hours of discontinuation of antimicrobial therapy. 6. Severity of illness (peak n-SOFA score) during the course of sepsisTimepoint: Occurrence of secondary outcome after the time of sepsis diagnosis, until the end of antimicrobial course, or 21 days, whichever is later.

Countries

India

Contacts

Public ContactRaghvendra Singh Patel

Bharati hospital and research centre

sujata.deshpande@gmail.com7275892180

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026